CoChat

Identification of pY654-β-catenin as a critical co-factor in hypoxia-inducible factor-1α signaling and tumor responses to hypoxia

Xi, Y, Wei, Y, Sennino, B, Ulsamer, A, Kwan, I, Brumwell, A N, Tan, K, Aghi, M K, McDonald, D M, Jablons, D M, Chapman, H A · 2013 · Oncogene
Cited by 32

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/onc.2012.530

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Research works printed but not linked: 32

  1. Polyak K, Weinberg RA . Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009; 9: 265–273. · DOI · Paper page
  2. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117: 927–939. · DOI · Paper page
  3. Thiery JP, Acloque H, Huang RY, Nieto MA . Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871–890. · DOI · Paper page
  4. Ruan K, Song G, Ouyang G . Role of hypoxia in the hallmarks of human cancer. J Cell Biochem 2009; 107: 1053–1062. · DOI · Paper page
  5. Paez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vinals F et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009; 15: 220–231. · DOI · Paper page
  6. Cannito S, Novo E, Compagnone A, Valfre di Bonzo L, Busletta C, Zamara E et al. Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. Carcinogenesis 2008; 29: 2267–2278. · DOI · Paper page
  7. Kaluz S, Kaluzova M, Stanbridge EJ . Regulation of gene expression by hypoxia: integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element. Clin Chim Acta 2008; 395: 6–13. · DOI · Paper page
  8. Kaidi A, Williams AC, Paraskeva C . Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol 2007; 9: 210–217. · DOI · Paper page
  9. Stemmer V, de Craene B, Berx G, Behrens J . Snail promotes Wnt target gene expression and interacts with beta-catenin. Oncogene 2008; 27: 5075–5080. · DOI · Paper page
  10. Yook JI, Li XY, Ota I, Hu C, Kim HS, Kim NH et al. A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat Cell Biol 2006; 8: 1398–1406. · DOI · Paper page
  11. Morin PJ . beta-catenin signaling and cancer. Bioessays 1999; 21: 1021–1030. · doi:10.1002/(sici)1521-1878(199912)22:1<1021::aid-bies6>3.0.co;2-p
  12. Polakis P . The oncogenic activation of beta-catenin. Curr Opin Genet Dev 1999; 9: 15–21. · DOI · Paper page
  13. Roura S, Miravet S, Piedra J, Garcia de Herreros A, Dunach M . Regulation of E-cadherin/Catenin association by tyrosine phosphorylation. J Biol Chem 1999; 274: 36734–36740. · DOI · Paper page
  14. Kim KK, Wei Y, Szekeres C, Kugler MC, Wolters PJ, Hill ML et al. Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest 2009; 119: 213–224.
  15. Kim Y, Kugler MC, Wei Y, Kim KK, Li X, Brumwell AN et al. Integrin alpha3beta1-dependent beta-catenin phosphorylation links epithelial Smad signaling to cell contacts. J Cell Biol 2009; 184: 309–322. · DOI · Paper page
  16. Ulsamer A, Wei Y, Kim KK, Tan K, Wheeler S, Xi Y et al. Axin pathway activity regulates in vivo pY654-beta-catenin accumulation and pulmonary fibrosis. J Biol Chem 2012; 287: 5164–5172. · DOI
  17. Lilien J, Balsamo J . The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin. Curr Opin Cell Biol 2005; 17: 459–465. · DOI · Paper page
  18. Zeng G, Apte U, Micsenyi A, Bell A, Monga SP . Tyrosine residues 654 and 670 in beta-catenin are crucial in regulation of Met-beta-catenin interactions. Exp Cell Res 2006; 312: 3620–3630. · DOI
  19. Jiang BH, Agani F, Passaniti A, Semenza GL . V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res 1997; 57: 5328–5335.
  20. Pham NA, Magalhaes JM, Do T, Schwock J, Dhani N, Cao PJ et al. Activation of Src and Src-associated signaling pathways in relation to hypoxia in human cancer xenograft models. Int J Cancer 2009; 124: 280–286. · DOI
  21. Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM . Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003; 3: 347–361. · DOI · Paper page
  22. Zhou G, Dada LA, Wu M, Kelly A, Trejo H, Zhou Q et al. Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1. Am J Physiol Lung Cell Mol Physiol 2009; 297: L1120–L1130. · DOI · Paper page
  23. Littlepage LE, Sternlicht MD, Rougier N, Phillips J, Gallo E, Yu Y et al. Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression. Cancer Res 2010; 70: 2224–2234. · DOI · Paper page
  24. Lluis JM, Buricchi F, Chiarugi P, Morales A, Fernandez-Checa JC . Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death. Cancer Res 2007; 67: 7368–7377. · DOI · Paper page
  25. Setsukinai K, Urano Y, Kakinuma K, Majima HJ, Nagano T . Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J Biol Chem 2003; 278: 3170–3175. · DOI · Paper page
  26. Sennino B, Ishiguro-Oonuma T, Wei Y, Naylor RM, Williamson CW, Bhagwandin V et al. Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors. Cancer Discov 2012; 2: 270–287. · DOI · Paper page
  27. Jones S, Chen WD, Parmigiani G, Diehl F, Beerenwinkel N, Antal T et al. Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci USA 2008; 105: 4283–4288. · DOI · Paper page
  28. Lu KV, Chang JP, Parachoniak CA, Pandika MM, Aghi MK, Meyronet D et al. VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell 2012; 22: 21–35. · DOI · Paper page
  29. Lou YW, Chen YY, Hsu SF, Chen RK, Lee CL, Khoo KH et al. Redox regulation of the protein tyrosine phosphatase PTP1B in cancer cells. FEBS J 2008; 275: 69–88. · DOI · Paper page
  30. Yang W, Xia Y, Ji H, Zheng Y, Liang J, Huang W et al. Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation. Nature 2011; 480: 118–122. · DOI · Paper page
  31. Grepin R, Pages G . Molecular mechanisms of resistance to tumour anti-angiogenic strategies. J Oncol 2010; 2010: 835680. · DOI
  32. Keunen O, Johansson M, Oudin A, Sanzey M, Rahim SA, Fack F et al. Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc Natl Acad Sci USA 2011; 108: 3749–3754. · DOI · Paper page

Cited by

Metadata

Authors
Xi, Y., Wei, Y., Sennino, B., Ulsamer, A., Kwan, I., Brumwell, A. N., Tan, K., Aghi, M. K., McDonald, D. M., Jablons, D. M., & Chapman, H. A.
Venue
Oncogene
Published
2012-12-17
Volume
32
Issue
42
Pages
5048-5057
ISSN
  • 0950-9232
  • 1476-5594
Cited by
32
References
13
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.